What are the best treatments for Truncus Arteriosus?

TL;DR: Truncus arteriosus is a rare congenital heart defect that requires surgical correction, typically within the first few weeks of life, to separate the pulmonary arteries from the single common vessel. Following initial repair, patients require lifelong monitoring by specialized cardiologists to manage potential complications such as valve regurgitation or conduit obstruction.

What is the primary treatment for Truncus Arteriosus?

The definitive treatment for Truncus Arteriosus is open-heart surgery performed in early infancy. During this procedure, the surgeon closes the ventricular septal defect (VSD) and detaches the pulmonary arteries from the single trunk, reattaching them to the right ventricle using a conduit or homograft. Because Truncus Arteriosus involves a single large vessel that supplies blood to both the lungs and the body, surgical intervention is critical to prevent irreversible pulmonary hypertension and heart failure.

What medications are used to manage Truncus Arteriosus?

Medications are typically used to support the heart before surgery or to manage residual symptoms afterward. Common categories include:

• Diuretics (e.g., furosemide) to reduce fluid overload.


• ACE inhibitors (e.g., enalapril, lisinopril) to reduce systemic vascular resistance and help the heart pump more efficiently.


• Inotropes (e.g., digoxin) to improve heart muscle contractility in infants with heart failure.

Which specialists are involved in the care team?

Managing Truncus Arteriosus requires a multidisciplinary approach due to the complexity of the defect. A typical care team includes:

1. Pediatric Cardiologists: To perform regular echocardiograms and monitor valve function.


2. Congenital Cardiothoracic Surgeons: To perform the initial repair and potential subsequent conduit replacements.


3. Electrophysiologists: To monitor for arrhythmias, which can occur in patients with Truncus Arteriosus.


4. Cardiac Nurse Specialists: To provide ongoing education and support for families.

Are there emerging treatments for Truncus Arteriosus?

Current research focuses on improving the longevity of the right ventricle-to-pulmonary artery conduits used in Truncus Arteriosus repair. Innovations include tissue-engineered conduits and percutaneous (catheter-based) valve replacements, which may allow patients to avoid repeated open-heart surgeries as they outgrow their original grafts.

Next steps

• Consult with a board-certified congenital cardiologist to establish a long-term surveillance plan.


• Join the DiseaseMaps.org community to connect with other families navigating the journey of Truncus Arteriosus.


• Keep a detailed medical diary of all surgical procedures and diagnostic imaging results.

Medical disclaimer: This information is for educational purposes only and does not replace professional medical advice; please consult your cardiology team for personalized treatment decisions.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Truncus Arteriosus


• Orphanet: Common arterial trunk


• American Heart Association (AHA): Congenital Heart Defects - Truncus Arteriosus


• PubMed: Long-term outcomes in patients with Truncus Arteriosus